Biotech Values

[DewDiligence]

AYTU acquires NEOS for approximately $0.74/sh in stock—a 34% premium to yesterday’s close:

https://ca.finance.yahoo.com/news/aytu-bioscience-neos-therapeutics-announce-110100289.html

Upon the effectiveness of the merger, Neos stockholders will be entitled to receive 0.1088 shares of common stock of Aytu for each share of Neos common stock held, after taking into account the one-for-ten reverse split of Aytu's common stock that was effected on December 8, 2020. The transaction will result in Neos stockholders owning approximately 30% of the fully diluted common shares of Aytu.

The boards of directors of both companies have approved the transaction.

AYTU’s stock was -21% yesterday, so evidently news of this deal leaked.